SY
Stan Yarbro
Director

Stan Yarbro insider trades: CALMARE THERAPEUTICS (CTTC) stock buys and sales

Director, CALMARE THERAPEUTICS Last trade Sep 4, 2012 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2005
4
Companies
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stan reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 4, 2012CTTC↑ Buy$7K
Aug 2, 2007VSEA↓ Sell$931K
Mar 8, 2007VSEA↓ Sell$1.2M
Aug 3, 2006VSEA↓ Sell$15K
Jun 21, 2006VSEA↓ Sell$680
May 4, 2006VSEA↓ Sell$16K
Mar 22, 2006VSEA↓ Sell$2K
Feb 1, 2006VSEA↓ Sell$21K
Nov 22, 2005VSEA↓ Sell$121K
Nov 21, 2005VSEA↓ Sell$581K
Nov 1, 2005VSEA↓ Sell$50K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Stan Yarbro's insider trades

Stan Yarbro is a director at CALMARE THERAPEUTICS (CTTC). Since Nov 1, 2005, Stan has reported 1 open-market purchase worth $7K and 10 sales worth $3.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (19 filings), grants and awards (11 filings), option exercises (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTTC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.